ISIN | LU0415391431 |
---|---|
Numero di valore | 3882623 |
Bloomberg Global ID | BBG000PM9VX9 |
Nome del fondo | Bellevue Medtech & Services B Cap |
Offerente del fondo |
Bellevue Asset Management AG
Zürich, Svizzera Telefono: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Offerente del fondo | Bellevue Asset Management AG |
Rappresentante in Svizzera |
Waystone Fund Services (Switzerland) SA Lausanne Telefono: 0041213111781 |
Distributore(i) |
Bank am Bellevue AG Küsnacht Telefono: +41 44 267 67 67 |
Asset class | Fondi azionari |
EFC Categoria | |
Classe di quote | Accumulation |
Paese di domicilio | Lussemburgo |
Condizioni all-unknown-emissione | Commissione di transazione a favore del fondo (contributo per la copertura delle spese d’investimento di nuovi mezzi collocati nel fondo) |
Condizioni al riscatto | Nessuna commissione di riscatto e/o altre commissioni a favore del fondo (riscatto al valore d’inventario) |
Strategia d'investimenti *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies. |
Particolarità |
Prezzo attuale * | 709.37 EUR | 31.10.2024 |
---|---|---|
Prezzo precedente * | 717.69 EUR | 30.10.2024 |
Max 52 settimani * | 736.66 EUR | 18.10.2024 |
Min 52 settimani * | 575.18 EUR | 10.11.2023 |
NAV * | 709.37 EUR | 31.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Prezzo minimo indicativo | ||
Attivo del fondo *** | 1'497'146'992 | |
Attivo della classe *** | ||
Trading Information SIX |
Performance YTD | +11.11% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
Performance YTD (in CHF) | +12.48% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
1 mese | -0.38% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 mesi | +4.26% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 mesi | +4.47% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 anno | +23.39% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 anni | +7.26% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 anni | +0.77% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 anni | +40.07% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Quota di partecipazione al capitale in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Utile totale del fondo in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota immobiliare in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Boston Scientific Corp | 9.83% | |
---|---|---|
Intuitive Surgical Inc | 9.79% | |
Abbott Laboratories | 9.63% | |
Stryker Corp | 8.91% | |
Medtronic PLC | 4.88% | |
Becton Dickinson & Co | 4.66% | |
Essilorluxottica | 3.98% | |
Alcon Inc | 3.88% | |
Edwards Lifesciences Corp | 3.26% | |
GE HealthCare Technologies Inc Common Stock | 2.53% | |
Ultimo aggiornamento dei dati | 31.08.2024 |
TER | 2.23% |
---|---|
Data TER | 01.02.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.19% |
SRRI ***
|
|
Data SRRI *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |